Hiroki Tojima

8PUBLICATIONS
34CO-AUTHORS
Radiation therapySocial program evaluationEpidemiological modellingAdolescent healthNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Jan 08, 2026
Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study.

Satoshi Takakusagi, Satoru Kakizaki, Yozo Yokoyama

|Apr 13, 2022
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy.

Ken Sato, Yuichi Yamazaki, Yuki Kanayama

|Oct 08, 2021
Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score.

Takeshi Hatanaka, Takashi Kosone, Naoto Saito

|Apr 10, 2021
Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression.

Atsushi Hiraoka, Takashi Kumada, Takeshi Hatanaka

Pageof 2